EP#49: Evangelos Evangelou, Co-Founder & CSO of OpenDNA
January 11, 2023Find it now
Timestamps
00:00 Intro
02:02 The potential of building a startup ecosystem in Ioannina
04:08 Background
05:41 Birth of the idea and the decision towards entrepreneurship
08:19 Tips on launching a company abroad
09:25 From the idea to the creation of OpenDNA
14:07 Who is the customer
15:45 Handling the ethical issues related to data collection
16:49 How big is the market?
18:51 The unique competitive advantage
20:10 What type of solution are you providing?
20:41 What is the customer pipeline for the next months?
21:53 Will Europe also proceed to adopt these types of solutions?
23:24 Fundraising, the Incubator In Israel
24:59 The growth of the team, the lab in Ioannina
26:14 The team
28:20 The exit strategy
29:23 The vision
More about the speaker:
On this episode, we welcome Dr Evangelou, the co-founder and CSO of OpenDNA.
OpenDNA has developed a cloud-based genomic precision medicine platform bound to change our lives!
By using AI to analyze each patient’s specific genetic and clinical data, this groundbreaking platform can predict if a person is at risk of developing cardiometabolic syndrome, enabling physicians to offer effective Personalized treatments to patients.
Future Goals?
To apply the technology to other complex polygenic disease states such as cancer, osteoporosis and autoimmune diseases.
ℹ Dr Evangelou is the co-founder and CSO of OpenDNA. He is a Professor of Clinical and Molecular Epidemiology at the University of Ioannina Medical School, GR and he holds a joint affiliation with Imperial College London, UK. He has been trained in Epidemiology and Biostatistics, and he works with genomics big data in order to decipher the genetic architecture of complex diseases
Stay up-to-date
with exclusive content.
Subscribe to our FREE newsletter and receive valuable content every month.
More Episodes
